Cycloart-25-ene-3,24-diol | CAS:10388-48-4

Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

J Anal Methods Chem.2022, 2022:2229500.

Food Chem.2020, 313:126079

Allergol Immunopathol (Madr).2022, 1;50(4):23-30.

Nutrients.2023, 15(12):2810.

Front Cell Dev Biol.2021, 9:638174.

J Bone Miner Res.2017, 32(12):2415-2430

Chem Biol Interact.2023, 378:110487.

Int J Mol Sci.2022, 23(20):12516.

Eur Endod J.2020, 5(1):23-27.

Cell J.2024, 26(8):496-504.

J Nat Prod. 2007 Jun;70(6):918-22.

Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.[Pubmed: 17503850 ]

METHODS AND RESULTS:
Forty-eight natural and semisynthetic cycloartane-type and related triterpenoids have been evaluated for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells as a primary screening test for anti-tumor promoters. In addition, these triterpenoids have been tested for their inhibitory effects on activation of (+/-)-(E)-methtyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor, as a primary screening test for anti-tumor initiators. All of the compounds tested exhibited inhibitory effects on both EBV-EA and NOR 1 activation.
CONCLUSIONS:
Six of these compounds having a C-24 hydroxylated side chain, viz., (24R)-cycloart-25-ene-3beta,24-diol (Cycloart-25-ene-3,24-diol ,9), (24R)-cycloartane-3beta,24,25-triol (11), (24S)-cycloartane-3beta,24,25-triol (12), (24xi)-24-methylcycloartane-3beta,24,241-triol (14), (24xi)-241-methoxy-24-methylcycloartane-3beta,24-diol (15), and (24xi)-24,25-dihydroxycycloartan-3-one (27), showed higher inhibitory effects than the others tested on both EBV-EA (IC50 values of 6.1-7.4 nM) and NOR 1 activation. Furthermore, compounds 14 and 15 exhibited inhibitory effects on skin tumor promotion in an in vivo two-stage mouse skin carcinogenesis test using 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter.

Product Name	Cycloart-25-ene-3,24-diol
CAS No.:	10388-48-4
Catalog No.:	CFN99054
Molecular Formula:	C₃₀H₅₀O₂
Molecular Weight:	442.7 g/mol
Purity:	>=98%
Type of Compound:	Triterpenoids
Physical Desc.:	Powder
Targets:	NOR 1
Source:	The herbs of Euphorbia segetalis
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: